We already know it works. Diabetics ulcers were the first indication studied and approved by the US FDA. It wasn’t pursued at the time because it didn’t appear particularly profitable, and at the time the FDA approval required the BTM dressing to be changed like any other dressing. Now that we have general approval for wound treatment as a biodegradable dressing this becomes a no-brainer. Go for it. Cash in the bank.
- Forums
- ASX - By Stock
- Ann: Chronic wound reimbursement study - first patient recruited
We already know it works. Diabetics ulcers were the first...
Featured News
Add PNV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.99 |
Change
0.010(0.51%) |
Mkt cap ! $1.371B |
Open | High | Low | Value | Volume |
$1.98 | $1.99 | $1.94 | $2.913M | 1.478M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 10216 | $1.96 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.99 | 3689 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 10216 | 1.955 |
6 | 42754 | 1.950 |
1 | 3692 | 1.945 |
2 | 5692 | 1.940 |
1 | 1550 | 1.935 |
Price($) | Vol. | No. |
---|---|---|
1.985 | 3689 | 1 |
2.000 | 43221 | 4 |
2.010 | 30000 | 1 |
2.050 | 10516 | 3 |
2.070 | 80000 | 1 |
Last trade - 16.10pm 06/11/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |